Articles citing this publication (6)
- The tyrosine kinase FER is responsible for the capacitation-associated increase in tyrosine phosphorylation in murine sperm. Alvau A, Battistone MA, Gervasi MG, Navarrete FA, Xu X, Sánchez-Cárdenas C, De la Vega-Beltran JL, Da Ros VG, Greer PA, Darszon A, Krapf D, Salicioni AM, Cuasnicu PS, Visconti PE. Development 143 2325-2333 (2016)
- Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases. Cowan-Jacob SW, Jahnke W, Knapp S. Future Med Chem 6 541-561 (2014)
- Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1. Huang H, Svoboda RA, Lazenby AJ, Saowapa J, Chaika N, Ding K, Wheelock MJ, Johnson KR. J Biol Chem 291 23208-23223 (2016)
- Proline-rich tyrosine kinase Pyk2 regulates deep vein thrombosis. Momi S, Canino J, Vismara M, Galgano L, Falcinelli E, Guglielmini G, Taranta GC, Guidetti GF, Gresele P, Torti M, Canobbio I. Haematologica 107 1374-1383 (2022)
- Novel pharmacological inhibitors demonstrate the role of the tyrosine kinase Pyk2 in adhesion and aggregation of human platelets. Guidetti GF, Zarà M, Canobbio I, Visconte C, Di Nunzio G, Torti M. Thromb Haemost 116 904-917 (2016)
- Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies. Fouad MA, Osman AA, Abdelhamid NM, Rashad MW, Nabawy AY, El Kerdawy AM. BMC Chem 18 29 (2024)